A potential worldwide prohibition on nicotine is moving closer to a formal international decision, with a UN vote anticipated in 2028. The process was set in motion after Palau asked the World Health Organization's expert committee on drug dependence to conduct a formal review of nicotine's legal status — a step that has drawn attention from public health researchers, regulators, and the manufacturers of a fast-growing category of tobacco-free consumer products.
How the Review Came About
Palau's referral to the WHO expert committee is an unusual but procedurally legitimate mechanism for placing a substance under international scrutiny. The committee's findings would inform any eventual UN deliberation, though a vote in 2028 would not automatically translate into a binding global ban. Still, the prospect has prompted renewed discussion about how nicotine — long regulated primarily through its association with tobacco — should be treated when it appears in products that contain no tobacco at all.
The Rise of Tobacco-Free Nicotine
Vapes and nicotine pouches, both of which rely on a synthetic form of nicotine rather than anything derived from the tobacco plant, have expanded substantially in popularity over the past two decades. Their rise has outpaced the regulatory frameworks designed to govern them. In many jurisdictions, oversight of these products has lagged well behind their market penetration, leaving a patchwork of rules that varies considerably from one country to the next.
This regulatory gap sits at the heart of the current debate. Smoking — the combustion of tobacco — remains the leading cause of preventable death globally, a fact that has driven numerous governments, including the United Kingdom, to introduce increasingly stringent restrictions on cigarettes and related tobacco products. The logic behind those measures has always centred on the specific harms of tobacco smoke: the carcinogens, the cardiovascular damage, the respiratory disease.
Tobacco-free nicotine products occupy a different position. They deliver the addictive compound without the combustion byproducts most closely associated with smoking-related illness. Whether that distinction is sufficient to place them in an entirely separate regulatory category — or whether nicotine's addictive properties alone justify prohibition — is the central question now being examined at an international level.
Addiction Without Combustion: A Contested Boundary
The framing of the debate has shifted in recent years. Earlier public health arguments against nicotine products were largely inseparable from arguments against tobacco. Now, with synthetic nicotine available in formats that carry no tobacco, regulators and researchers are being asked to assess the compound on its own terms.
Proponents of stricter controls argue that dependence itself constitutes a harm worth preventing, regardless of whether a product causes cancer or cardiovascular disease at the rates associated with cigarettes. Critics of that position contend that conflating addiction with catastrophic physical harm risks distorting policy — and could, in theory, undermine harm-reduction strategies that have encouraged some smokers to switch away from combustible tobacco.
The stakes of that argument are considerable. As the Guardian editorial notes, the question is essentially whether addiction and dependence — absent the more severe health consequences of smoking — are sufficient grounds for an outright ban. It is a question with no obvious consensus answer, and one that the WHO committee will need to address with some precision if its findings are to carry weight.
The Legacy of Tobacco Regulation
The historical context matters here. Decades of tobacco control policy were built on evidence of catastrophic harm. Former WHO director-general Gro Harlem Brundtland captured the prevailing view in 2000, when she stated that
a cigarette is the only consumer product which when used as directed kills its consumer
That framing helped galvanise international action, culminating in the WHO Framework Convention on Tobacco Control. Whether a similarly robust international consensus can be built around nicotine in its tobacco-free forms — where the harm profile is less clearly defined — remains to be seen.
What Happens Next
The WHO expert committee's review will be a key staging post before any UN vote. Its conclusions are likely to be closely scrutinised by governments, industry groups, and public health advocates alike. The 2028 timeline allows for a period of evidence-gathering and political negotiation, though the outcome is far from predetermined.
What is clear is that the rapid growth of vapes and nicotine pouches has forced a reckoning with questions that tobacco regulation never fully had to confront: namely, what society's relationship with nicotine should look like when the most lethal delivery mechanism — the cigarette — is removed from the equation.